Wenfang Tian
P.R. China
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
RIPPLY1 suppresses cancer cell stemness via targeting TBX19 in CTNNB1 -mutated hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: December 08, 2024
The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
Journal: Journal of hepatology
Published: November 27, 2022
TOX deficiency facilitates the differentiation of IL-17A-producing γδ T cells to drive autoimmune hepatitis.
Journal: Cellular & molecular immunology
Published: January 17, 2022
Guanine Nucleotide-Binding Protein G(i) Subunit Alpha 2 Exacerbates NASH Progression by Regulating Peroxiredoxin 1-Related Inflammation and Lipophagy.
Journal: Hepatology (Baltimore, Md.)
Published: December 09, 2020
ARRB1 ameliorates liver ischaemia/reperfusion injury via antagonizing TRAF6-mediated Lysine 6-linked polyubiquitination of ASK1 in hepatocytes.
Journal: Journal of cellular and molecular medicine
Published: January 20, 2020
Modulation of IR as a therapeutic target to prevent NASH using NRF from Diceratella elliptica (DC.) jonsell. Strong Nrf2 and leptin inducer as well as NF-kB inhibitor.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 03, 2019
ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation.
Journal: Journal of hepatology
Published: September 11, 2019
TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma.
Journal: Journal of hepatology
Published: December 28, 2018
Exosomes derived from exhausted CD8+ T cells impaired the anticancer function of normal CD8+ T cells.
Journal: Journal of medical genetics
Published: April 19, 2018
Corrigendum: Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
Journal: Scientific reports
Published: July 28, 2016
Protein inhibitor of activated STAT 4 (PIAS4) regulates liver fibrosis through modulating SMAD3 activity.
Journal: Journal of biomedical research
Published: April 09, 2016
Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
Journal: Scientific reports
Published: February 19, 2016
Last Updated: 09/26/2026